Denmark · Investor

BankInvest

Last cheque observed Mar 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series CSeries AGrowthBiopharmaBiotechnology

Cheques on record
0%of best year0cheques in 12 months, 13 on record
Since the last cheque5336days00hrs00min00sec
Median round$22MRounds led0 of 13Sole investor1 roundsExits1 from the portfolioMostly inUnited States, 38%
Pitch BankInvest

BankInvest highlights

  1. 01

    13 rounds on record

  2. 02

    Mostly Series C and Series A: 54% of its rounds

  3. 03

    Sole investor in 1 rounds, median $8.0M

  4. 04

    1 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiopharmaBiotechnology
Based in
Copenhagen K, Denmark
Cold pitches
Not stated

The record

Every round we can evidence, newest first13 appearances

  1. 2012

    1 round

  2. Mar
    iosil EnergyGrowth · US · prnewswire.com$14MWith 9 others
  3. 2009

    1 round

  4. Jun
    EnecsysSeries A · GB$9.9MWith 1 other
  5. 2008

    4 rounds

  6. Sept
    NujiraSeries C · GB · nujira.com$18MWith 5 others
  7. Jul
    SulfurCellGrowth · DE$134MWith 5 others
  8. Jul
    SulfurCellSeries A · DE · news.cnet.com$134MWith 5 others
  9. May
    CamSemiSeries C · GB · deals.venturebeat.com$8.0MSole investor
  10. 2007

    2 rounds

  11. Dec
    Santaris PharmaSeries C · DK$30MWith 7 others
  12. Nov
    AtraverdaSeries B · GB · pehub.com$22MWith 6 others
  13. 2005

    1 round

  14. Mar
    Borean PharmaSeries A · DK · bioportfolio.com$5.2MWith 3 others
  15. 2004

    2 rounds

  16. May
    Altus PharmaceuticalsSeries C · US$51MWith 4 others
  17. Jan
    Cyclacel PharmaceuticalsSeries D · US · evaluategroup.com$39MWith 15 others
  18. 2003

    1 round

  19. Aug
    BioStratumVenture · US$9.5MWith 3 others
  20. 2001

    1 round

  21. Oct
    Altus PharmaceuticalsVenture · US$35MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

Santaris PharmaBought by Roche$450MAug 2014

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as BankInvest. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about BankInvest

What does BankInvest invest in?

BankInvest invests most often at Series C and Series A (54% of the rounds on record), in sectors such as Biopharma and Biotechnology.

How active is BankInvest?

13 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2012.

How big are BankInvest's cheques?

The median round it joins is $22M.

Does BankInvest lead rounds?

Rarely, if at all: none of its 13 investments on record names it as the lead.

Where does BankInvest invest?

Most of the companies it backs are in the United States (38%), the United Kingdom (31%) and Germany (15%).

Is BankInvest investing now?

No investments in the last 12 months; the latest was in Mar 2012.

Who does BankInvest invest alongside?

Most often AIG Investments (2 rounds together), Demeter Partners (2 rounds together) and EnerTech Capital (2 rounds together).

What kind of investor is BankInvest?

BankInvest is a VC firm based in Copenhagen K, Denmark.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it